RayzeBio, Inc. Common Stock (RYZB) stock surged +0.02%, trading at $62.49 on NASDAQ, up from the previous close of $62.48. The stock opened at $62.49, fluctuating between $62.48 and $62.50 in the recent session.
RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company’s lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs). It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California.
Employees | 88 |
Beta | 0 |
Sales or Revenue | N/A |
5Y Sales Change% | N/A |
Fiscal Year Ends | N/A |
Sector | Healthcare |
Industry | Biotechnology |
RayzeBio, Inc. Common Stock (NASDAQ: RYZB) stock price is $62.49 in the last trading session. During the trading session, RYZB stock reached the peak price of $62.50 while $62.48 was the lowest point it dropped to. The percentage change in RYZB stock occurred in the recent session was 0.02% while the dollar amount for the price change in RYZB stock was $0.01.
The NASDAQ listed RYZB is part of Biotechnology industry that operates in the broader Healthcare sector. RayzeBio, Inc. Common Stock designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
RYZB's closing price is 248.13% higher than its 52-week low of $17.95 where as its distance from 52-week high of $62.51 is -0.03%.
Number of RYZB employees currently stands at 88.
RYZB could be contacted at phone 0 and can also be accessed through its website. RYZB operates from , , , United States.
RYZB stock volume for the day was 282.72K shares. The average number of RYZB shares traded daily for last 3 months was 745.49K.
The market value of RYZB currently stands at $3.75B with its latest stock price at $62.49 and 60.02M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com